EBG00000313325 - n.1290C>T
Drug resistance types
3 Sensitive
1 RR-TB
1 HR-TB
2 MDR-TB
3 Pre-XDR-TB
0 XDR-TB
18 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.9 | 3 |
| lineage4.1.2.1 | 3 |
| lineage2.2.1 | 3 |
| lineage1.2.1.2 | 1 |
| lineage4.8 | 2 |
| lineage1.1.3.1 | 2 |
| lineage3 | 2 |
| lineage1.2.1.2.1 | 1 |
| lineage3.1.2.1 | 1 |
| lineage4.1.1.3 | 2 |
| lineage4.3.3;lineage4.9 | 1 |
| lineage1.1.1 | 1 |
| lineage4.3.3 | 2 |
| lineage1.2.2.2 | 1 |
| La1.4 | 1 |
| lineage4.1.1.2 | 1 |
| lineage4.2.1 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 28 |
Geographic prevalence
Country level data for this variant is available for 3 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR6046250 | Other | lineage4.9 | None | SRR3675245 | Other | lineage4.1.2.1 | None | SRR18003031 | HR-TB | lineage2.2.1 | None | SRR20969475 | Other | lineage1.2.1.2 | None | SRR12420628 | MDR-TB | lineage2.2.1 | None | ERR1163055 | MDR-TB | lineage4.8 | None | ERR4553952 | RR-TB | lineage1.1.3.1 | None | ERR4821616 | Other | lineage1.1.3.1 | None | ERR4818831 | Other | lineage3 | None | ERR3256275 | Sensitive | lineage1.2.1.2.1 | ph | ERR4815022 | Other | lineage3.1.2.1 | None | ERR9117747 | Sensitive | lineage4.8 | None | ERR4821962 | Other | lineage4.1.1.3 | gb | SRR14334194 | Pre-XDR-TB | lineage2.2.1 | None | SRR6832644 | Other | lineage4.3.3;lineage4.9 | None | SRR21658550 | Other | lineage1.1.1 | None | ERR10796632 | Other | lineage4.3.3 | None | ERR4819175 | Other | lineage4.1.1.3 | gb | SRR21240055 | Other | lineage4.1.2.1 | None | SRR12199449 | Sensitive | lineage1.2.2.2 | None | ERR4816417 | Other | lineage4.9 | None | ERR4820193 | Other | lineage3 | None | SRR16278274 | Other | La1.4 | None | SRR7069473 | Other | lineage4.1.1.2 | None | SRR11349211 | Pre-XDR-TB | lineage4.3.3 | None | ERR4822138 | Other | lineage4.1.2.1 | None | SRR7069391 | Other | lineage4.9 | None | SRR7755654 | Pre-XDR-TB | lineage4.2.1 | None |
|---|
